Biologics and airway remodeling in asthma: early, late, and potential preventive effects
Allergy · 2025-02 · 80 (2) · 408-422
DOI: 10.1111/all.16382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 09.11.2024. Verfasst von G Varricchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Asthma, Airway Remodeling, Biological Products, Anti-Asthmatic Agents. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Although airway remodeling in severe and/or fatal asthma is still considered irreversible, its individual components as a cause of clinical symptoms and/or lung function changes remain largely unknown. While inhaled glucocorticoids have not consistently been shown to affect airway remodeling, biologics targeting specific pathways of airway inflammation have been shown to improve lung function, mucus plugging, and airway structural changes that can exceed those seen with glucocorticoids. This superiority of biologic treatment, which cannot be solely explained by insufficient doses or limited durations of glucocorticoid therapies, needs to be further explored. For this field of research, we propose a novel classification of the potential effects of biologics on airway remodeling into three temporal effects: early effects (days to weeks, primarily modulating inflammatory processes), late effects (months to years, predominantly affecting structural changes), and potential preventive effects (outcomes of early treatment with biologics). For the identification of potential preventive effects of biologics, we call for studies exploring the impact of early biological treatment on airway remodeling in patients with moderate‐to‐severe asthma, which should be accompanied by a long‐term evaluation of clinical parameters, biomarkers, treatment burden, and socioeconomic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
- Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
- World Allergy Organization (WAO) Center of Excellence, Naples, Italy.
- Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council, Naples, Italy.
- Department of Pneumology and Critical Care Medicine, University of Rostock, Rostock, Germany.
- Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
ORCID-Profile: G Varricchi, R Poto, M Lommatzsch, J C Virchow
Zitieren
APA
Varricchi, G., Poto, R., Lommatzsch, M., Brusselle, G., Braido, F., Virchow, J. C., & Canonica, G. W. (2025). Biologics and airway remodeling in asthma: early, late, and potential preventive effects. Allergy, 80(2), 408-422. https://doi.org/10.1111/all.16382
Vancouver
Varricchi G, Poto R, Lommatzsch M, Brusselle G, Braido F, Virchow JC, et al. Biologics and airway remodeling in asthma: early, late, and potential preventive effects. Allergy. 2025;80(2):408-422. doi:10.1111/all.16382
BibTeX
@article{Varricchi2025,
author = {Varricchi, G and Poto, R and Lommatzsch, M and Brusselle, G and Braido, F and Virchow, J C and Canonica, G W},
title = {Biologics and airway remodeling in asthma: early, late, and potential preventive effects},
journal = {Allergy},
year = {2025},
volume = {80},
number = {2},
pages = {408--422},
doi = {10.1111/all.16382}
}
EUVIMED